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Abstract Vigilin is a member of the KH protein family and 
contains 14 tandemly arranged potential RNA-binding domains. 
Between KH domains 2 and 3 we have identified a nuclear 
localization sequence by cloning this sequence into the NH2- 
terminal region of phage T7 RNA polymerase as a reporter 
protein and by showing its transfer into the nucleus. Furthermore 
we provide experimental evidence that Vigilin is present both in 
the nucleus and in the cytoplasm in similar concentrations. These 
observations upport the notion that Vigilin may shuttle between 
nucleus and cytoplasm presumably in contact with RNA 
molecules. 
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1. Introduction 
A great number  of nucleic acid binding proteins are im- 
ported into the nucleus following their synthesis in the cyto- 
plasm. This process is mediated by cytoplasmic proteins which 
recognize a nuclear localization sequence (NLS) in the trans- 
ported protein and mediate its translocation through the nu- 
clear pores [1~,]. It has also been observed that the NLS is 
frequently located adjacent o or overlapping with the nucleic 
acid binding site [5]. A characteristic RNA-b ind ing moti f  is 
the KH domain [6-81, which is generally present in one to a 
few copies in most of the known members of this protein 
family, which have been detected either in the nucleus [9 11] 
or in the cytoplasm [12-15]. Vigilin is a unique member of this 
group in that it contains 14 KH domains in series, which 
account for the major part  of the 150 kDA protein. Vigilin 
is an ubiquitous protein and is highly conserved between 
avian and mammal ian species [16-18]. There is also circum- 
stantial evidence that Vigilin is part  of a tRNA-b inding com- 
plex associated with the rough endoplasmic reticulum (rER) 
[191. 
In the present study we have analyzed whether the nuclear 
localization signal located on a predicted loop region between 
KH domains 2 and 3 of Vigilin is able to direct a reporter 
protein (phage T7 RNA polymerase) to the nucleus of eukar- 
yotic cells. The subcellular deposit ion of this chimeric protein 
was traced by immunocytochemistry.  In concert with immu- 
nogold labeling for electronmicrographs and immunoblot  
analysis of subcellular extracts we show that Vigilin is present 
in similar amounts in both  the nuclear and the cytoplasmic 
protein pool of HEp-2 cells, indicating a functional involve- 
ment in the two compartments.  
*Corresponding author. Fax: (49) (451) 500 3637. 
2. Material and methods 
2.1. Anti-Vigilin antibody 
A chicken Vigilin cDNA fragment coding for KH domains 3-7 was 
expressed as a I~-galactosidase fusion protein in E. eoli. The fusion 
protein was purified by affinity chromatography and used to immu- 
nize rabbits according to standard protocols. The antiserum obtained 
(FP3) is monoreactive on immunoblots and precipitates human Vig- 
ilin in a cell free translation system. 
2.2. Cloning of the Vigilin NLS into the NH2-terminus of phage T7 
RNA polymerase 
Two 60mer oligonucleotides comprising the sense (5'-aattcgctcgcat- 
caagaagatttatgaggagaagaaaaagaagactacaaccattgcag-Y) and antisense 
(5'-aattctgcaatggttgtagtcttctttttcttctcctcataaatcttcttgatgcgagcg-3') 
strand coding for 20 amino acids comprising the Vigilin NLS were 
annealed to generate EcoRI sites on both ends of the resulting double 
stranded DNA fragment. The pSVNUG-GI-A expression vector [20], 
coding for 5 vector specific amino acids, the SV40 NLS and amino 
acids 11-883 of the T7 RNA polymerase was cut with EcoRI to 
remove the SV40 NLS. The gel-purified vector was ligated with the 
double stranded oligonucleotide, generating either a chimeric T7 
RNA polymerase with the Vigilin NLS (clone 'VIG-NLS-T7') or a 
hydrophobic sequence at its NH2-terminus (clone 'VIG-REV-T7'), 
depending on the orientation of the insertion. Identity of the clones 
was determined by DNA sequencing on both strands. 
2.3, Transfection and immunostaining of COS-7 cells (ATCC CRL 
1651) 
1 Ixg of each vector was LipofectAmine transfected (3 × 10 ~ cells/ 
transfection) using a commercially available kit (Life Technologies, 
Eggenstein, FRG) according to the manufacturer's in tructions. After 
48 h, cells were fixed wih 30% methanol/1.75% formaldehyde for 15 
min, washed twice with phosphate buffered saline (PBS) and permea- 
bilized with acetone/HzO (1:1) for 5 min, with acetone for 5 min and 
with acetone/H20 at -20°C for 5 rain. Cells were washed again with 
PBS, and endogenous peroxidase was blocked by a 15 min incubation 
in 0.5% H202 in PBS. The anti-T7 RNA polymerase antibody was 
allowed to bind overnight at room temperature in PBS/0.1% BSA. 
For staining of cells with the immunoperoxidase staining technique 
the Vectastain Elite ABC kit (Camon, Wiesbaden, Germany) was used 
according to the manufacturer's instructions. 
2.4. Immunostaining of HEp-2 cells (ATCC CCL 23) 
For permeabilization f the cell membrane cells were incubated in 
methanol for 10 min and subsequently placed in acetone for 1 rain at 
-20°C (fix A). For additional permeabilization f the nuclear mem- 
brane we used acetone/H20 (1:1) for 5 min, acetone for 5 min and 
acetone/H20 at -20°C for 5 min (fix B). Cells were stained as de- 
scribed above. 
2.5. Preparation of protein fractions from HEp-2 cells 
In order to avoid disruption of nuclear complexes, we used a mod- 
ification of the method originally described by Dignam et al. [21]. 
5× 108 subconfluent HEp-2 cells were washed twice with ice-cold 
PBS, scraped from their dishes with a cell lifter and pelleted by cen- 
trifugation at 4°C, 600×g, 5 min. After an additional washing step 
with PBS the compact cell volume was roughly estimated and 5 vol. 
ice-cold hypotonic buffer (10 mM HEPES/KOH, pH 7.9, 0.1 mM 
EDTA, 0.1 mM EGTA, 10 mM KCI, 0.75 mM spermidine, 0.15 
mM spermine, 1 mM DTT, 10 mM benzamidine, 0.5 mM PMSF) 
were added and incubated for 10 min on ice. Cells were then lysed 
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Fig. I. Location of the NLS  in human Vigilin. (A) Amino acids 275-307 of human Vi~lin. The NLS  is boxed. The secondary structure predic- 
tion and the respective prediction accuracies are shown below the sequence (H = (x-helical; L = loop; E = extended (~-sheet); • = no prediction 
with reasonable accuracy). The vertical stippled line demarcates the position of the intron which separates exon 6 (coding for KH domain 2) 
and exon 7 (coding for KH domain 3). (B) The residues underlined in (A) were inserted into the pSVNU-GI -A  expression vector [20], replacing 
the SV40-NLS of this construct. The amino acid sequence encoded by the two resulting expression constructs is partially shown. Insertion of 
the double stranded oligonucleotide into the EcoR[ site (arrows) generated VIG-NLS-T7 (insertion in the correct orientation) and VIG-REV-  
T7 (insertion in reversed orientation as negative control). The amino terminal residues MDKAE are vector-encoded, the residues F and E at 
the N- and C-termini of the inserts are generated by the cloning procedure. 
by 10 strokes in a pestle-B dounce homogenizer. 0.1 vol. of sucrose 
buffer (consisting of 9 vol. of 75% sucrose and 1 vol. 10 × salt solution 
(0.5 M HEPES/KOH pH 7.9, 0.1 M KC1, 2 mM EDTA, 10 mM 
DTT, 7.5 mM spermidine, 1.5 mM spermine)) was added to the sus- 
pension and nuclei were pelleted by centrifugation (10 rain, 1500 ×g, 
4°C). The supernatant was dialysed against dialysis buffer (20 mM 
HEPES/KOH pH 7.9, 20% glycerine, 100 mM KC1, 0.2 mM EDTA, 
0.5 mM DTT, 0.5 mM PMSF) and used as the cytoplasmic protein 
fraction. The nuclei were resuspended in 1 ml nuclear resuspension 
buffer (NRB, 20 mM HEPES/KOH pH 7.9, 0.2 mM EDTA, 2 mM 
EGTA, 25% glycerine, 0.75 mM spermidine, 0.15 mM spermine, 10 
mM benzamidine, 0.5 mM PMSF). Nuclei were lysed by stirring 30 
min on ice and debris was pelleted by ultracentrifugation (30 rain, 
117 000 × g, 4°C). The supernatant was dialyzed as above, precipitated 
and referred to as the first soluble nuclear protein fraction. The pellet 
was resuspended in NRB containing 0.4 M (NH4)2SO4, stirred and 
centrifuged as above to precipitate the insoluble nuclear proteins• The 
supernatant was dialyzed and precipitated. This pool consists of so- 
luble nuclear proteins free of any contamination by membranes of the 
endoplasmic reticulum. The protein concentration of each fraction 
was determined according to the method of Bradford [22]. 
2.6. Electron microscopical studies 
Samples of rat pancreas were fixed with glutaraldehyde and reduced 
osmium [23] and embedded in LR White [24]. Ultrathin sections were 
mounted on 250-mesh nickel grids, blocked by 0.5% BSA in TBS and 
incubated with affinity purified FP3 (on Vigilin bound to nitrocellu- 
lose membranes), diluted 1:500 in TBS for 18 h at 22°C. For electron 
optical detection, FP3 was visualized with donkey anti-rabbit lgG, 
coupled to 12 nM gold (Dianova, Hamburg, Germany). For negative 
controls, incubations were carried out with FP3 serum which had 
been preadsorbed on Vigilin. 
3. Results and discussion 
3.1. Vigilin contains a functional nuclear localization signal 
A SV40-type NLS consensus equence consisting of four 
consecutive lysyl residues is located between KH domains 2 
and 3 of chicken and human Vigilin. Secondary structure 
prediction using the 'predict protein'  EMBL server [25] sug- 
gests that the highly charged Vigilin NLS is located on a loop 
A B 
Fig. 2. The Vigilin-NLS as part of the chimeric T7 RNA polymerase. T7 RNA polymerase containing the Vigilin-NLS is directed to the nu- 
cleus (A), while the control T7 RNA polymerase containing a hydrophobic stretch of residues in place of the NLS stays in the cytoplasm (B). 
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Fig. 3. Vigilin is present both in the cytoplasm and in the nucleus. HEp-2 cells stained with the affinity purified anti-Vigilin antibody (FP3). 
Permeabilization f plasma membrane only (A) and of plasma nd nuclear membranes (B). 
between two secondary structures and will thus be accessible 
to the importins [1,2] (Fig. 1A). This structure prediction (an 
a-helix at the C-terminal end of domain 2 and a [3-strand at 
the NH2-terminus of domain 3) is in excellent accordance with 
NMR data obtained for KH domain 5 of human Vigilin [26]. 
A functional assay for the putative NLS was performed by 
inserting a short stretch of amino acids comprising the four 
lysyl residues into the NH2-terminus of phage T7 RNA poly- 
merase (Fig. 1B). This reporter protein was chosen because it
has previously been shown that it is transported into the nu- 
cleus by insertion of the SV40-NLS into its NH2-terminal 
region [20]. Tests for compartimental deposition of the chi- 
meric protein were performed using COS-7 cells transfected 
with expression plasmids encoding either T7 RNA polymerase 
with the Vigilin-NLS (VIG-NLS-T7) or with a hydrophobic 
stretch generated by inverse insertion of the same oligonucleo- 
tide (VIG-REV-T7) into the expression vector. Fig. 2 clearly 
shows that the VIG-NLS-T7 construct is directed to the nu- 
cleus while the control construct VIG-REV-T7 remains in the 
cytoplasm. No staining with the anti-T7 RNA polymerase 
antiserum was observed in mock transfected cells, while a 
result identical to that shown in Fig. 2A was obtained with 
A B 
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Fig. 4. Subcellular localization of Vigilin by immuno-electron micrography of ultrathin sections of rat liver. (A) Arrows point to gold particles 
in a region showing parts of the nucleus (N), the rough endoplasmic reticulum (rER) and a mitochondrium (M). (B) Extensive staining of the 
outer membrane of the rER. 
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Fig. 5. lmmunoblot analysis of protein fractions from HEp-2 cells. 
Identical amounts of protein from each fraction were loaded on the 
gels and stained with affinity purified anti-Vigilin antibody FP3 (A); 
anti-ct-SSR antibody (B); and anti-Lamine (type A) antibody (C). 
Molecular weight markers are shown on the right. Lanes 1: cyto- 
plasmic proteins (20 lag of 21.2 mg total protein from this fraction 
was loaded on the gels). Lanes 2: first soluble (= low salt) nuclear 
fraction (20 ~tg of 5.5 mg). Lanes 3: insoluble nuclear proteins (20 
ktg of 5 mg). Lanes 4: nuclear proteins oluble in 0.4 M (53%) 
(NH4)2804 (20 p.g of 9.7 rag). 
an expression vector coding for T7 RNA polymerase preceded 
by the original SV40 NLS (data not shown). 
A screening of nuclear KH proteins revealed NLS consen- 
sus sequences in Merl [9], in human and Xenopus hnRNP K 
[10] and in the eukaryotic ribosomal $3 proteins, which are 
imported into the nucleus for ribosomal assembly, but not in 
Nova [11]. However, Vigilin is the only KH protein with the 
NLS located adjacent o a putative RNA binding site. As 
Vigilin consists mainly of 14 putative RNA-binding domains 
it is possible that Vigilin functions as a transporter protein for 
RNA from the nucleus to the cytoplasm and one may hy- 
pothesize that the binding of RNA adjacent to the NLS might 
mask the NLS in order to prevent re-import into the nucleus 
[5]. (The ability of in vitro translated human Vigilin to bind to 
single stranded ribo-oligonucleotides has been demonstrated; 
D. Willkomm and S.K., unpublished ata.) 
3.2. Vigilin is present both in the cytoplasm and in the nucleus 
When cells are treated so as to allow the anti-Vigilin anti- 
body to penetrate both the cell membrane and the nuclear 
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envelope an even staining of the entire cell is observed (Fig. 
3B). In contrast, the nucleus is spared from immunostaining 
when the plasma membrane only is permeabilized (Fig. 3A). 
Using immuno-electron microscopy on tissue sections with 
affinity purified anti-Vigilin antibody FP3, the gold label 
was found inside the nucleus and at the outer surface of the 
rER (Fig. 4). Vigilin does not show any subnuclear accumula- 
tion, e.g. in the nucleoli. No signals above background were 
obtained in other cytoplasmic ompartments (e.g. mitochon- 
dria, lysosomes) in good accordance with organelle fractiona- 
tion experiments which demonstrated the presence of Vigilin 
in the microsomal fraction (data not shown) and with the 
pattern of immunostaining showing a network-like structure 
in the cytoplasm (Fig. 3). 
To explain the cellular distribution pattern of Vigilin one 
may assume that (i) only a portion of the newly synthesized 
Vigilin is imported into the nucleus, while another portion is 
captured by cytoplasmic factors and directed to the rER (note 
that Vigilin does not contain a signal sequence for insertion 
into the ER); (ii) all of the newly synthesized Vigilin is im- 
ported into the nucleus and the rER fraction represents pro- 
tein exported from the nucleus. According to present knowl- 
edge the latter pathway seems to be more likely since a partial 
capture would require an unknown factor competing with the 
importins for Vigilin. Although specific nuclear export signals 
have been recently identified in a few proteins [27-29], there is 
also evidence arguing for nuclear export by a default pathway 
[30,31]. At present experimental evidence is lacking which 
could show whether Vigilin shuttles continuously across the 
nuclear envelope like some nucleolar proteins [32], the proges- 
terone receptor [33] or some of the hnRNPs [27], or is stably 
anchored at the ER after it had passed by the nucleus. 
3.3. Vigilin does not accumulate ither in the nucleus or in the 
cytoplasm during culture of HEp-2 cells 
To confirm the immunocytochemical d ta which show Vig- 
ilin in the nucleus and the cytoplasm (Fig. 3) subfractions of 
HEp-2 cells were prepared and probed with the anti-Vigilin 
antibody FP3. Concomitant contaminations of nuclear prep- 
arations with endoplasmic membranes were monitored with 
an antibody against he ~-subunit of the signal sequence re- 
ceptor (c~-SSR [34]). Type A lamins were used as nuclear 
marker proteins. Fig. 5 shows a strong signal for Vigilin in 
the cytoplasm (Fig. 5A, lane 1) as well as in the first fraction 
of soluble nuclear proteins, obtained as the supernatant from 
lysed and pelleted nuclei (Fig. 5A, lane 2). Since both c~-SSR 
and Vigilin are detected in the latter fraction with the same 
relative signal strength as in the cytoplasm (Fig. 5A,B, lanes 1 
and 2), the presence of Vigilin in the first nuclear extract is 
due to membrane associated protein. A Vigilin containing 
though membrane free preparation of soluble nuclear proteins 
was obtained by resuspending the pelleted nuclei in a buffer 
containing 0.4 M ammonium sulfate (Fig. 5A,B, lane 4), 
whereas virtually no Vigilin could be detected in the insoluble 
nuclear protein fraction (Fig. 5A, lane 3). Identical results 
were obtained with the chicken embryonal fibroblast cell 
line CEC-32 (data not shown). Apparently, Vigilin can be 
solubilized from human and chicken nuclei and its nuclear 
concentration compares well with that in the cytoplasm. 
This observation renders Vigilin different from other pro- 
teins shuttling between the cytoplasm and the nucleus, which 
are predominantly nuclear at equilibrium conditions [27,32]. 
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The heat shock related proteins B3 and B4, which are equally 
concentrated in cytoplasm and nucleus in Xenopus oocytes 
[35], accumulate in the nucleus following heat stress. The 
mechanisms which govern the subcellular distribution of 
Vigilin are not known at present. 
3.4. Conclusion 
In the present study we have demonstrated, for the first 
time, a functional NLS in a KH protein, Vigilin. The nearness 
of this NLS to a putative RNA binding domain suggests a 
functional relationship between the two motifs. Vigilin is also 
the only KH protein as yet with an unambiguous occurrence 
in both the cytoplasm and the nucleus, which suggests that it 
may shuttle between the two compartments. Together with the 
previous findings that Vigilin is a ubiquitous and highly con- 
served protein and contains 14 putative RNA binding do- 
mains, the presented ata suggest a role in RNA transport. 
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